acetylcysteine
Generic: acetylcysteine
Labeler: padagis us llcDrug Facts
Product Profile
Brand Name
acetylcysteine
Generic Name
acetylcysteine
Labeler
padagis us llc
Dosage Form
INJECTION
Routes
Active Ingredients
acetylcysteine 200 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0574-0805
Product ID
0574-0805_b123834f-a908-4e77-bf87-32dffefa20f1
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA021539
Listing Expiration
2027-12-31
Marketing Start
2012-12-20
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05740805
Hyphenated Format
0574-0805
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acetylcysteine (source: ndc)
Generic Name
acetylcysteine (source: ndc)
Application Number
NDA021539 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/mL
Packaging
- 4 VIAL in 1 CARTON (0574-0805-30) / 30 mL in 1 VIAL
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "b123834f-a908-4e77-bf87-32dffefa20f1", "openfda": {"nui": ["N0000175429", "N0000175961", "N0000008867", "N0000175960", "N0000175776", "N0000175547"], "unii": ["WYQ7N0BPYC"], "rxcui": ["465377"], "spl_set_id": ["9d305722-e74f-4f48-8d2c-0daa99144749"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Glutathione Concentration [PE]"], "pharm_class_epc": ["Antidote [EPC]", "Antidote for Acetaminophen Overdose [EPC]", "Mucolytic [EPC]"], "pharm_class_moa": ["Reduction Activity [MoA]"], "manufacturer_name": ["Padagis US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 VIAL in 1 CARTON (0574-0805-30) / 30 mL in 1 VIAL", "package_ndc": "0574-0805-30", "marketing_start_date": "20121220"}], "brand_name": "acetylcysteine", "product_id": "0574-0805_b123834f-a908-4e77-bf87-32dffefa20f1", "dosage_form": "INJECTION", "pharm_class": ["Antidote [EPC]", "Antidote for Acetaminophen Overdose [EPC]", "Decreased Respiratory Secretion Viscosity [PE]", "Increased Glutathione Concentration [PE]", "Mucolytic [EPC]", "Reduction Activity [MoA]"], "product_ndc": "0574-0805", "generic_name": "Acetylcysteine", "labeler_name": "Padagis US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acetylcysteine", "active_ingredients": [{"name": "ACETYLCYSTEINE", "strength": "200 mg/mL"}], "application_number": "NDA021539", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20121220", "listing_expiration_date": "20271231"}